Rimouski (Quebec) – innoVactiv, a Canadian company dedicated to the development of science-based specialty ingredients, today announces that it is joining forces with FrauPharma srl to offer NeuroPeak PS® ingredients to North American dietary supplement manufacturers. The commercial launch of this new product line is planned at the upcoming SupplySide West tradeshow (October 7-8, Las Vegas, NV).
Founded in 2011 by Dr. Francesco Autuori, FrauPharma established its headquarters and production facility in the outskirt of Milan (Italy), in a region known as a center of excellence in the active ingredients industry. FrauPharma products are manufactured in its state-of-the-art pharmaceutical cGMP facility. “Our certifications are the highest and strictest that ingredient manufacturers can obtain and ensure dietary supplement manufacturers that they get only the quality, consistency and reliability they deserve”, said Dr. Autuori.
“innoVactiv has been consistently looking to add new and innovative specialty ingredients to reflect our growing commercial presence. Given our enviable reputation and our commitment to our customers, we wanted to make sure any company we would partner with would abide by the same levels of excellence and dedication. That is what we found in FrauPharma”, said Patrice Dionne, CEO of innoVactiv.
This partnership positions innoVactiv as a true value-creator in the North American ingredient marketplace. “NeuroPeak PS® various potencies with quality levels that will certainly meet or exceed expectations of supplement manufacturers. We are thrilled to launch these new ingredients at SupplySide West and would love to invite all interested manufacturers at Booth #1669 or to set up a meeting in advance with us during the event”, said Jocelyn Bérubé, Executive & Scientific Director, Health & Nutrition of innoVactiv.
About innoVactiv
innoVactiv’s mission is to develop and supply innovative health ingredients with scientific demonstrations of efficacy and safety for the nutraceutical and cosmeceutical industries.
